Bactolife raises €29.2M Series B round
8 January 2026· Copenhagen, Denmark· health, biotech, animal_health, precision_fermentation, b2b
To move its Binding Protein technology from development into commercialization, as the company prepares for its first human health product launch in the US in 2026
About Bactolife
Stage
Series B
Headquarters
Copenhagen, Denmark
Founded
2017
Team Size
21–50
Sectors
healthbiotechanimal_healthprecision_fermentationb2b